Additionally, it was found that in the 5×FAD AD mouse, this TAT-TrkB peptide improved cognitive ability, improved synaptic plasticity defects, and prevented Tau pathological progression in vivo [89]. Here, NTRK2 is linked to Alzheimer disease.